195 related articles for article (PubMed ID: 26617867)
1. Prognostic significance of HOXD13 expression in human breast cancer.
Zhong ZB; Shan M; Qian C; Liu T; Shi QY; Wang J; Liu Y; Liu Y; Huang YX; Pang D
Int J Clin Exp Pathol; 2015; 8(9):11407-13. PubMed ID: 26617867
[TBL] [Abstract][Full Text] [Related]
2. HOXD13 methylation status is a prognostic indicator in breast cancer.
Zhong Z; Shan M; Wang J; Liu T; Xia B; Niu M; Ren Y; Pang D
Int J Clin Exp Pathol; 2015; 8(9):10716-24. PubMed ID: 26617782
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.
Zhao P; Lu Y; Jiang X; Li X
Cancer Sci; 2011 May; 102(5):1107-11. PubMed ID: 21276138
[TBL] [Abstract][Full Text] [Related]
5. LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.
Li N; Zheng Y; Xuan C; Lin Z; Piao L; Liu S
Int J Clin Exp Pathol; 2015; 8(10):12893-900. PubMed ID: 26722481
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of MAGE-A9 predicts unfavorable outcome in breast cancer.
Xu X; Tang X; Lu M; Tang Q; Zhang H; Zhu H; Xu N; Zhang D; Xiong L; Mao Y; Zhu J
Exp Mol Pathol; 2014 Dec; 97(3):579-84. PubMed ID: 25445503
[TBL] [Abstract][Full Text] [Related]
7. Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.
Tang J; Deng R; Luo RZ; Shen GP; Cai MY; Du ZM; Jiang S; Yang MT; Fu JH; Zhu XF
Breast Cancer Res Treat; 2012 Jul; 134(2):549-60. PubMed ID: 22585231
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.
Li Z; Liu Q; Piao J; Hua F; Wang J; Jin G; Lin Z; Zhang Y
BMC Cancer; 2016 Aug; 16(1):681. PubMed ID: 27562113
[TBL] [Abstract][Full Text] [Related]
9. Correlation and prognostic value of SIRT1 and Notch1 signaling in breast cancer.
Cao YW; Li WQ; Wan GX; Li YX; Du XM; Li YC; Li F
J Exp Clin Cancer Res; 2014 Nov; 33(1):97. PubMed ID: 25420528
[TBL] [Abstract][Full Text] [Related]
10. High fibroblast growth factor 19 (FGF19) expression predicts worse prognosis in invasive ductal carcinoma of breast.
Buhmeida A; Dallol A; Merdad A; Al-Maghrabi J; Gari MA; Abu-Elmagd MM; Chaudhary AG; Abuzenadah AM; Nedjadi T; Ermiah E; Al-Thubaity F; Al-Qahtani MH
Tumour Biol; 2014 Mar; 35(3):2817-24. PubMed ID: 24248542
[TBL] [Abstract][Full Text] [Related]
11. High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.
Shubbar E; Helou K; Kovács A; Nemes S; Hajizadeh S; Enerbäck C; Einbeigi Z
BMC Cancer; 2013 Feb; 13():47. PubMed ID: 23374458
[TBL] [Abstract][Full Text] [Related]
12. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.
Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ
Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
[TBL] [Abstract][Full Text] [Related]
14. HOX D13 expression across 79 tumor tissue types.
Cantile M; Franco R; Tschan A; Baumhoer D; Zlobec I; Schiavo G; Forte I; Bihl M; Liguori G; Botti G; Tornillo L; Karamitopoulou-Diamantis E; Terracciano L; Cillo C
Int J Cancer; 2009 Oct; 125(7):1532-41. PubMed ID: 19488988
[TBL] [Abstract][Full Text] [Related]
15. PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast.
Qian L; Gao X; Huang H; Lu S; Cai Y; Hua Y; Liu Y; Zhang J
Oncotarget; 2017 Mar; 8(13):21444-21453. PubMed ID: 28423522
[TBL] [Abstract][Full Text] [Related]
16. Nuclear-cytoplasmic PARP-1 expression as an unfavorable prognostic marker in lymph node‑negative early breast cancer: 15-year follow-up.
Donizy P; Pietrzyk G; Halon A; Kozyra C; Gansukh T; Lage H; Surowiak P; Matkowski R
Oncol Rep; 2014 Apr; 31(4):1777-87. PubMed ID: 24535158
[TBL] [Abstract][Full Text] [Related]
17. Association of ultrasonographic features with NGX6 expression and prognosis in invasive ductal breast carcinoma.
Xiao J; Zhou Y; Zhu W
Int J Clin Exp Pathol; 2015; 8(6):6458-65. PubMed ID: 26261522
[TBL] [Abstract][Full Text] [Related]
18. Gli1 is a potential cancer stem cell marker and predicts poor prognosis in ductal breast carcinoma.
Ni W; Yang Z; Qi W; Cui C; Cui Y; Xuan Y
Hum Pathol; 2017 Nov; 69():38-45. PubMed ID: 28965964
[TBL] [Abstract][Full Text] [Related]
19. High ASMA
Amornsupak K; Jamjuntra P; Warnnissorn M; O-Charoenrat P; Sa-Nguanraksa D; Thuwajit P; Eccles SA; Thuwajit C
Clin Breast Cancer; 2017 Oct; 17(6):441-452.e2. PubMed ID: 28533055
[TBL] [Abstract][Full Text] [Related]
20. The Relation of Parafibromin Expression with Clinicopathological Factors in Invasive Breast Carcinomas.
Karaarslan S; Genç B; Nart A; Börekçi İ; Buğdayci MH
Turk Patoloji Derg; 2016; 32(1):8-14. PubMed ID: 26832176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]